$175 | Single User
$350 | Site License
$525 | Enterprise License

GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report
[Report Updated: 28-08-2018]

Published by Marketline: 28 Aug 2018 | 220991 | In Stock
Related Topics: GlaxoSmithKline

Introduction

GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report

Summary

GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

GlaxoSmithKline plc (GSK or 'the company') is a leading global provider of pharmaceuticals, vaccines and consumer healthcare products. It is primarily involved in developing, manufacturing and commercializing pharmaceuticals, vaccines and consumer healthcare products. These cater to the needs of HIV, respiratory, cancer, anti-virals, metabolic, cardiovascular and urogenital, dermatology, anti-bacterials and several other rare diseases. It merchandise and sell these products through wholesalers, pharmacies, hospitals, physicians and other groups worldwide. GSK is headquartered in England, the UK.

Scope

- Detailed information on GlaxoSmithKline Plc required for business and competitor intelligence needs

- A study of the major internal and external factors affecting GlaxoSmithKline Plc in the form of a SWOT analysis

- An in-depth view of the business model of GlaxoSmithKline Plc including a breakdown and examination of key business segments

- Intelligence on GlaxoSmithKline Plc's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about GlaxoSmithKline Plc, such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of GlaxoSmithKline Plc and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess GlaxoSmithKline Plc as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on GlaxoSmithKline Plc's business structure, strategy and prospects.

Table of Contents
for GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report [Report Updated: 28-08-2018]

  • Table of Contents

    Company Snapshot 2

    Table of Contents 5

    GlaxoSmithKline Plc: Company Overview 9

    GlaxoSmithKline Plc: Overview and Key Facts 9

    GlaxoSmithKline Plc: Overview 9

    GlaxoSmithKline Plc: Key Facts 9

    GlaxoSmithKline Plc: Key Employees 11

    GlaxoSmithKline Plc: Key Employee Biographies 13

    GlaxoSmithKline Plc: Major Products and Services 20

    GlaxoSmithKline Plc: Company History 22

    GlaxoSmithKline Plc: Management Statement 37

    GlaxoSmithKline Plc: Locations and Subsidiaries 39

    GlaxoSmithKline Plc: Key Competitors 41

    GlaxoSmithKline Plc: Company Analysis 42

    GlaxoSmithKline Plc: Business Description 42

    GlaxoSmithKline Plc: SWOT Analysis 44

    GlaxoSmithKline Plc: SWOT Overview 44

    GlaxoSmithKline Plc: Strengths 44

    GlaxoSmithKline Plc: Weaknesses 45

    GlaxoSmithKline Plc: Opportunities 46

    GlaxoSmithKline Plc: Threats 47

    GlaxoSmithKline Plc: Corporate Financial Deals Activity 49

    GlaxoSmithKline Plc: Financial Deals Overview 49

    GlaxoSmithKline Plc: Targets and Partners 51

    GlaxoSmithKline Plc: Top Deals 2014 - 2018YTD* 54

    GlaxoSmithKline Plc: Advisors 55

    GlaxoSmithKline Plc: Top Legal Advisors 55

    GlaxoSmithKline Plc: Top Financial Advisors 55

    GlaxoSmithKline Plc: Mergers and Acquisitions 57

    GlaxoSmithKline Plc: Corporate Venturing 58

    GlaxoSmithKline Plc: Capital Raising 59

    GlaxoSmithKline Plc: Partnership 60

    GlaxoSmithKline Plc: Divestments 61

    GlaxoSmithKline Plc: Recent Developments 62

    GlaxoSmithKline Plc: News and Events Summary 62

    GlaxoSmithKline Plc: Business Expansion 66

    GlaxoSmithKline Plc: Business Reorganization 66

    GlaxoSmithKline Plc: Contracts 67

    GlaxoSmithKline Plc: Financial Deals 67

    GlaxoSmithKline Plc: Financial Performance 68

    GlaxoSmithKline Plc: Market Developments 68

    GlaxoSmithKline Plc: Red Flags/DistressSignals 69

    GlaxoSmithKline Plc: Regulatory and Legal Events 69

    GlaxoSmithKline Plc: Strategy and Operations 70

    Appendix 71

    Contact Us 71

    Methodology 71

    About MarketLine 72

List Of Tables
in GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report [Report Updated: 28-08-2018]

List of Tables

Table 1: GlaxoSmithKline Plc: Key Facts

Table 2: GlaxoSmithKline Plc: Key Employees

Table 3: GlaxoSmithKline Plc: Locations and Subsidiaries

Table 4: GlaxoSmithKline Plc: Key Competitors

Table 5: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)

Table 6: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)

Table 7: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)

Table 8: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)

Table 9: GlaxoSmithKline Plc: Targets and Partners

Table 10: GlaxoSmithKline Plc: Top Deals 2014 - 2018YTD*

Table 11: GlaxoSmithKline Plc: Legal Advisor Ranking by Value (US$m)

Table 12: GlaxoSmithKline Plc: Financial Advisor Ranking by Value (US$m)

Table 13: GlaxoSmithKline Plc: M&A Volume and Value Trend (2014 - YTD*2018)

Table 14: GlaxoSmithKline Plc: M&A Activity by Geography (2014 - YTD*2018)

Table 15: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)

Table 16: GlaxoSmithKline Plc: Corporate Venturing by Geography (2014 - YTD*2018)

Table 17: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)

Table 18: GlaxoSmithKline Plc: Capital Raising by Deal Type (2014 - YTD*2018)

Table 19: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2014 - YTD*2018)

Table 20: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2014 - YTD*2018)

Table 21: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2014 - YTD*2018)

Table 22: GlaxoSmithKline Plc: Divestments by Geography (2014 - YTD*2018)

Table 23: GlaxoSmithKline Plc: News and Events Summary

Table 24: GlaxoSmithKline Plc: Business Expansion

Table 25: GlaxoSmithKline Plc: Business Reorganization

Table 26: GlaxoSmithKline Plc: Contracts

Table 27: GlaxoSmithKline Plc: Financial Deals

Table 28: GlaxoSmithKline Plc: Financial Performance

Table 29: GlaxoSmithKline Plc: Market Developments

Table 30: GlaxoSmithKline Plc: Red Flags/DistressSignals

Table 31: GlaxoSmithKline Plc: Regulatory and Legal Events

Table 32: GlaxoSmithKline Plc: Strategy and Operations

List Of Figures, Charts and Diagrams
in GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report [Report Updated: 28-08-2018]

List of Figures

Figure 1: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (TTM*)

Figure 2: GlaxoSmithKline Plc: M&A Activity by Geography (TTM*)

Figure 3: GlaxoSmithKline Plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)

Figure 4: GlaxoSmithKline Plc: M&A Average Deal Size - Value (US$m)

Figure 5: GlaxoSmithKline Plc: M&A Volume and Value Trend (2014 - YTD*2018)

Figure 6: GlaxoSmithKline Plc: M&A Activity by Geography (2014 - YTD*2018)

Figure 7: GlaxoSmithKline Plc: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)

Figure 8: GlaxoSmithKline Plc: Corporate Venturing by Geography (2014 - YTD*2018)

Figure 9: GlaxoSmithKline Plc: Capital Raising Volume and Value Trend (2014 - YTD*2018)

Figure 10: GlaxoSmithKline Plc: Capital Raising by Deal Type (2014 - YTD*2018)

Figure 11: GlaxoSmithKline Plc: Partnership Volume and Value Trend (2014 - YTD*2018)

Figure 12: GlaxoSmithKline Plc: Partnership Trend by Deal Type (2014 - YTD*2018)

Figure 13: GlaxoSmithKline Plc: Divestments Volume and Value Trend (2014 - YTD*2018)

Figure 14: GlaxoSmithKline Plc: Divestments by Geography (2014 - YTD*2018)

Additional Details

Publisher

Marketline

Publisher Information

Reference

220991 |

Number of Pages

73

Report Format

PDF

Marketline Reports

Related Reports

TitleDate PublishedPrice fromMore Details
GlaxoSmithKline Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
GlaxoSmithKline K.K. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline K.K. (GSK Japan) a subsidiary of GlaxoSmithKline Plc is a pharmaceutical comp...
10 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Pharmaceuticals Limited (GLAXO) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline Pharmaceuticals Limited (GSK India) is a pharmaceutical company that manufact...
04 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Plc (GSK) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryGlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufact...
04 Mar 2016 by Global Data USD $250 More Info
GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile
SummaryGlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufact...
24 Feb 2016 by Global Data USD $250 More Info
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
SummaryGlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline Consumer Nigeria) a subsidiary of Glaxo...
09 Jan 2016 by Global Data USD $300 More Info
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review
SummaryGlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline Consumer Nigeria) a subsidiary of Glaxo...
08 Nov 2015 by Global Data USD $300 More Info
Physician Views: Is GlaxoSmithKline's BRAF/MEK combo making headway in V600 mutation-positive melanoma patients?
Scope Although the clinical promise of cancer immunotherapies looks poised to see these products gai...
22 Jul 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Assessing the launch of GlaxoSmithKline's Breo Ellipta
Scope It remains early in the launch, but available evidence suggests that GlaxoSmithKline's Breo El...
21 Jan 2014 by FirstWord Pharma USD $695 More Info
Physician Views: Can GlaxoSmithKline strike early with Anoro? / What role will dosing, inhaler type play in uptake of LAMA/LABA combinations for COPD?
ScopeThis year looks set to be one of notable evolution for the US chronic obstructive pulmonary dis...
01 Aug 2013 by FirstWord Pharma USD $695 More Info

This report is published by Marketline

Download Free Report Summary PDF

GlaxoSmithKline Plc - Strategy, SWOT and Corporate Finance Report [Report Updated: 28-08-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • 360i Research
  • 99Strategy
  • Allied Market Research
  • Asia Market Information & Development Co.
  • Azoth Analytics
  • BioInformant
  • Black Swan Analysis
  • Canadean
  • CBR Pharma Insights
  • CRI
  • Current Analysis
  • Current Partnering
  • Daedal Research
  • Data bridge
  • Delve Insight
  • DPI Research
  • FirstWord Pharma
  • Future Market Insights
  • GBI Research
  • Global Data
  • Global Markets Direct
  • Global Research and Data Services GRDS
  • GMR Data
  • HeyReport
  • HongChun
  • HTStec
  • ICD Research
  • iGATE Research
  • IMARC
  • Industry ARC
  • Inkwood Research
  • IQ4I
  • Jain PharmaBiotech
  • Kelly Scientific
  • La Merie
  • Lifescience Intellipedia
  • LP Information
  • Market Data Forecast
  • Market Research Future
  • Marketline
  • MarketsandMarkets
  • McDerson
  • MedMarket Diligence
  • Meticulous Research
  • MicroMarketMonitor
  • MIReports
  • Mordor Intelligence LLC
  • MP Advisors
  • Occams Business Research
  • Prof Research
  • Progressive Markets
  • ProGrow Pharma Partners
  • Renub
  • Research Impact
  • RNCOS
  • Rockville Research
  • S&P Consulting
  • StratisticsMRC
  • The Business Research Company
  • Triton Market Research
  • Venture Planning Group (VPG)